PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 188 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $658,000 | -40.5% | 15,300 | -32.0% | 0.00% | -50.0% |
Q3 2018 | $1,106,000 | +26.8% | 22,500 | -17.3% | 0.00% | +100.0% |
Q2 2018 | $872,000 | -3.8% | 27,200 | -6.5% | 0.00% | 0.0% |
Q1 2018 | $906,000 | -27.3% | 29,100 | +6.6% | 0.00% | -50.0% |
Q4 2017 | $1,246,000 | +28.6% | 27,300 | +5.8% | 0.00% | +100.0% |
Q3 2017 | $969,000 | -33.5% | 25,800 | -15.6% | 0.00% | -50.0% |
Q2 2017 | $1,458,000 | -11.9% | 30,563 | -15.7% | 0.00% | -33.3% |
Q1 2017 | $1,654,000 | +21.7% | 36,263 | -13.8% | 0.00% | +50.0% |
Q4 2016 | $1,359,000 | -36.1% | 42,063 | -32.4% | 0.00% | -50.0% |
Q3 2016 | $2,128,000 | -17.2% | 62,200 | -18.4% | 0.00% | -20.0% |
Q2 2016 | $2,570,000 | -32.6% | 76,200 | +5.8% | 0.01% | -28.6% |
Q1 2016 | $3,815,000 | -33.5% | 72,000 | -3.6% | 0.01% | -36.4% |
Q4 2015 | $5,736,000 | +90.1% | 74,700 | +1.8% | 0.01% | +83.3% |
Q3 2015 | $3,017,000 | -40.2% | 73,400 | +2.9% | 0.01% | -33.3% |
Q2 2015 | $5,042,000 | -29.4% | 71,300 | -11.3% | 0.01% | -30.8% |
Q1 2015 | $7,144,000 | +10.5% | 80,400 | +10.3% | 0.01% | +18.2% |
Q4 2014 | $6,463,000 | -22.1% | 72,900 | -14.8% | 0.01% | -21.4% |
Q3 2014 | $8,296,000 | +14.0% | 85,600 | +8.1% | 0.01% | +16.7% |
Q2 2014 | $7,275,000 | +27.9% | 79,200 | -2.6% | 0.01% | +20.0% |
Q1 2014 | $5,690,000 | +29.7% | 81,300 | +6.6% | 0.01% | +25.0% |
Q4 2013 | $4,386,000 | +17.1% | 76,300 | -2.1% | 0.01% | +14.3% |
Q3 2013 | $3,746,000 | +58.7% | 77,900 | -4.3% | 0.01% | +40.0% |
Q2 2013 | $2,361,000 | – | 81,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |